Chapel Hill-based pharmaceutical company Pozen was hit with a two class-action lawsuits Friday - three days after the company's lead migraine drug candidate was rejected by the U.S. Food and Drug Administration. The Pennsylvania-based law firm of Schiffrin & Barroway and New York-based Geller Rudman filed the suits in the U.S. District Court for the Middle District of North Carolina, which covers Chapel Hill. Named as defendants in both suits are Pozen, company CEO John Plachetka, former Chief Financial Officer Matthew E. Czajkowski and John R. Barnhardt, the company's vice president of finance.
Posted by Editor at June 8, 2004 03:14 PM